What is the market capitalization of Valion Bio, Inc.?

Valion Bio, Inc. (VBIO) has a market capitalization of approximately 2,064,531 USD.

Where can I buy VBIO in Canada?

VBIO can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

VBIO

Valion Bio, Inc.

Valion Bio, Inc. (VBIO) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 2 million USD (micro-cap).

Details

Price0.65 USD

Market cap2.06 M USD

Payout ratio0.00%

ROE-82.69%

Debt / Equity38.42%

SectorHealthcare

Websitetivichealth.com

Updated 2h ago

Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.